Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling
Cancer Letters · 2024
DOI: 10.1016/j.canlet.2024.216665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024. Verfasst von Bo Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury, Neuro-repair and Regeneration in Central Nervous System, Ministry of Education a…. Hauptthemen laut MEDLINE: Glioma, Glioblastoma, Naphthalenes, Piperazines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Tianjin Medical University, National Natural Science Foundation of China, Xinxiang Medical University.
Abstract (Originalsprache)
Glioblastoma (GBM) is an extremely aggressive tumor associated with a poor prognosis that impacts the central nervous system. Increasing evidence suggests an inherent association between glucose metabolism dysregulation and the aggression of GBM. Polo-like kinase 4 (PLK4), a highly conserved serine/threonine protein kinase, was found to relate to glioma progression and unfavorable prognosis. As revealed by the integration of proteomics and phosphoproteomics, PLK4 was found to be involved in governing metabolic processes and the PI3K/AKT/mTOR pathway. For the first time, this study supports evidence demonstrating that PLK4 activated PI3K/AKT/mTOR signaling through direct binding to AKT1 and subsequent phosphorylating AKT1 at S124, T308, and S473 to promote tumorigenesis and glucose metabolism in glioma. In addition, PLK4-mediated phosphorylation of AKT1 S124 significantly augmented the phosphorylation of AKT1 S473. Therefore, PLK4 exerted an influence on glucose metabolism by stimulating PI3K/AKT/mTOR signaling. Additionally, the expression of PLK4 protein exhibited a positive correlation with AKT1 phosphorylation in glioma patient tissues. These findings highlight the pivotal role of PLK4-mediated phosphorylation of AKT1 in glioma tumorigenesis and dysregulation of glucose metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Neurological Institute, Key Laboratory of Post-Neuro Injury, Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital, Tianjin,…
- Department of Hepatopancreatobiliary Surgery, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
- Department of Genetics, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China. Electronic address: yuren0925@tmu.edu.cn.
- Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China. Electronic address: fcczhenyw@zzu.edu.cn.
Förderung
- Tianjin Medical University
- National Natural Science Foundation of China
- Xinxiang Medical University
- Science and Technology Program of Hunan Province
Zitieren
APA
Wang, B., Zhang, X., Li, Z. S., Wei, C., Yu, R. Z., Du, X. Z., He, Y. J., Ren, Y., Zhen, Y. W., & Han, L. (2024). Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.216665
Vancouver
Wang B, Zhang X, Li ZS, Wei C, Yu RZ, Du XZ, et al. Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling. Cancer Letters. 2024. doi:10.1016/j.canlet.2024.216665
BibTeX
@article{Wang2024,
author = {Wang, Bo and Zhang, Xiaoyang and Li, Ze-Sheng and Wei, Cheng and Yu, Run-Ze and Du, Xue-Zhi and He, Ying-Jie and Ren, Yu and Zhen, Ying-Wei and Han, Lei},
title = {Polo-like kinase 4 promotes tumorigenesis and glucose metabolism in glioma by activating AKT1 signaling},
journal = {Cancer Letters},
year = {2024},
doi = {10.1016/j.canlet.2024.216665}
}
EUVIMED